The Forum for Collaborative HIV Research convened the 12th HCV Drug Development Advisory Group (DrAG) Meeting in London, UK in conjunction with the 49th annual meeting of the European Association for the Study of the Liver. The meeting was held on April 8, 2014 at the Grange City Hotel.
Topics of discussion included:
- Control arms and efficacy standards
- Demonstrating clinical benefit of SVR in patients with advanced liver disease
- Global implementation strategies and opportunities for industry collaboration and partnerships
Background Materials
Islam, Z. Access to HCV diagnostics and treatment for most-at-risk populations in Ukraine.
Presentations
Session 1: Control Arms, Efficacy Standards and the Design of Future Clinical Trials
Session 2: Global HCV Access To Care
Clifford Samuel
The Steering Committee for this project includes:
Patrick Harrington, PhD - Center for Drug Evaluation and Research, Food and Drug Administration
Daria Hazuda, PhD - Merck Research Laboratories
Ira Jacobson, MD - Weill Medical College of Cornell University
Donald Jensen, MD, FACP - University of Chicago Medical Center
Filip Josephson, MD, PhD - European Medicines Agency
Tara Kieffer, PhD - Vertex Pharmaceuticals, Inc.
Veronica Miller, PhD - Forum for Collaborative HIV Research
Jeffrey Murray, MD, MPH - Center for Drug Evaluation and Research, Food and Drug Administration
Neil Parkin, PhD - Data First Consulting
Jean-Michel Pawlotsky, MD, PhD* - Universite Paris Est
Gaston Picchio, PhD*- Janssen Pharmaceuticals
Stuart Ray, MD - Johns Hopkins University School of Medicine
Kimberly Struble, PharmD - Center for Drug Evaluation and Research, Food and Drug Administration
Tracy Swan - Treatment Action Group
Heiner Wedemeyer, MD - Medizinische Hochschule Hannover
* Co-Chair
